SUPN insider transactions
Supernus Pharmaceuticals Inc. (SUPN) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.
Recent Form 3, 4, and 5 filings for SUPN
- SEC Form 4 filed by Supernus Pharmaceuticals Inc.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. acquired 12,500 shares, disposed of 12,500 shares and sold $1,763,124 worth of shares (35,000 units at $50.37), increasing direct ownership by 1% to 1,241,144 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Hudson Frederick M. sold $271,725 worth of shares (5,369 units at $50.61), decreasing direct ownership by 8% to 60,413 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. converted options into 38,640 shares and covered exercise/tax liability with 16,574 shares, increasing direct ownership by 2% to 1,228,644 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Tech. Ops. Officer Mottola Frank converted options into 3,750 shares, covered exercise/tax liability with 1,793 shares and sold $87,074 worth of shares (1,623 units at $53.65), increasing direct ownership by 2% to 18,440 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Senior Vice-President & CFO Dec Timothy C converted options into 6,000 shares and covered exercise/tax liability with 2,883 shares, increasing direct ownership by 61% to 8,232 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Commercial Operations Horich William Todd converted options into 7,500 shares, covered exercise/tax liability with 3,455 shares and sold $483,797 worth of shares (8,877 units at $54.50), closing all direct ownership in the company (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- New insider Horich William Todd claimed ownership of 4,832 shares (SEC Form 3)3 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Gemayel Georges sold $1,002,811 worth of shares (18,787 units at $53.38) and exercised 7,905 shares at a strike of $25.30, decreasing direct ownership by 29% to 27,277 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by President, CEO Khattar Jack A.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by SVP, Chief Tech. Ops. Officer Mottola Frank4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Senior Vice-President & CFO Dec Timothy C4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Medical Officer Rubin Jonathan covered exercise/tax liability with 675 shares and was granted 1,250 shares, increasing direct ownership by 5% to 13,341 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Tech. Ops. Officer Mottola Frank covered exercise/tax liability with 977 shares and was granted 1,875 shares, increasing direct ownership by 5% to 18,106 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Sr. VP of IP, CSO Bhatt Padmanabh P. was granted 1,250 shares and covered exercise/tax liability with 650 shares, increasing direct ownership by 4% to 17,044 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Senior Vice-President & CFO Dec Timothy C was granted 2,500 shares and covered exercise/tax liability with 1,279 shares, increasing direct ownership by 31% to 5,115 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Senior Vice-President & CFO Dec Timothy C was granted 4,625 shares and covered exercise/tax liability with 2,369 shares, increasing direct ownership by 138% to 3,894 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Newhall Charles W Iii was granted 4,475 shares, increasing direct ownership by 4% to 124,119 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Hudson Frederick M. was granted 4,475 shares, increasing direct ownership by 7% to 65,782 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Barlow Carrolee was granted 4,475 shares, increasing direct ownership by 20% to 27,045 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Sr. VP of IP, CSO Bhatt Padmanabh P. was granted 3,125 shares and covered exercise/tax liability with 1,581 shares, increasing direct ownership by 10% to 16,444 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Tech. Ops. Officer Mottola Frank was granted 3,125 shares and covered exercise/tax liability with 1,641 shares, increasing direct ownership by 9% to 17,208 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Medical Officer Rubin Jonathan was granted 3,125 shares and covered exercise/tax liability with 1,643 shares, increasing direct ownership by 13% to 12,766 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Gemayel Georges exercised 15,000 shares at a strike of $12.98 and was granted 4,475 shares, increasing direct ownership by 104% to 38,159 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Sensenig Bethany converted options into 4,475 shares and sold $228,265 worth of shares (4,475 units at $51.01) (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Senior Vice-President & CFO Dec Timothy C4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Sr. VP of IP, CSO Bhatt Padmanabh P.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by SVP, Chief Medical Officer Rubin Jonathan4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by SVP, Chief Tech. Ops. Officer Mottola Frank4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by President, CEO Khattar Jack A.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Director Gemayel Georges4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Director Barlow Carrolee4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Director Sensenig Bethany4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Director Newhall Charles W Iii4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Director Hudson Frederick M.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Hudson Frederick M. exercised 15,000 shares at a strike of $12.98, increasing direct ownership by 32% to 61,307 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Tech. Ops. Officer Mottola Frank exercised 20,000 shares at a strike of $28.82 and sold $1,008,150 worth of shares (20,000 units at $50.41) (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Sr. VP of IP, CSO Bhatt Padmanabh P. converted options into 1,500 shares and sold $31,552 worth of shares (710 units at $44.44), increasing direct ownership by 6% to 14,508 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Newhall Charles W Iii exercised 15,000 shares at a strike of $12.98, increasing direct ownership by 14% to 119,644 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by Sr. VP of IP, CSO Bhatt Padmanabh P.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 81,250 shares at a strike of $25.30 and sold $3,029,336 worth of shares (59,900 units at $50.57), increasing direct ownership by 2% to 1,206,578 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Newhall Charles W Iii sold $1,269,234 worth of shares (25,000 units at $50.77), decreasing direct ownership by 19% to 104,644 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. converted options into 39,320 shares and covered exercise/tax liability with 15,325 shares, increasing direct ownership by 2% to 1,185,228 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. sold $91,506 worth of shares (1,904 units at $48.06) and exercised 2,267 shares at a strike of $25.30, increasing direct ownership by 0.03% to 1,161,233 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 53,785 shares at a strike of $25.30 and sold $1,931,116 worth of shares (40,173 units at $48.07), increasing direct ownership by 1% to 1,160,870 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 11,510 shares at a strike of $25.30 and sold $414,371 worth of shares (8,588 units at $48.25), increasing direct ownership by 0.26% to 1,147,258 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 13,688 shares at a strike of $25.30 and sold $491,485 worth of shares (10,235 units at $48.02), increasing direct ownership by 0.30% to 1,144,336 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Medical Officer Rubin Jonathan converted options into 1,875 shares and covered exercise/tax liability with 840 shares, increasing direct ownership by 10% to 11,015 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 47,940 shares at a strike of $12.98 and sold $1,393,899 worth of shares (29,513 units at $47.23), increasing direct ownership by 2% to 1,140,883 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. sold $779,921 worth of shares (16,587 units at $47.02) and exercised 27,060 shares at a strike of $12.98, increasing direct ownership by 0.94% to 1,122,456 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Chief Tech. Ops. Officer Mottola Frank exercised 5,000 shares at a strike of $39.40 and sold $229,350 worth of shares (5,000 units at $45.87) (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by SVP, Chief Medical Officer Rubin Jonathan4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SEC Form 4 filed by President, CEO Khattar Jack A.4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 8,074 shares at a strike of $25.30 and sold $292,645 worth of shares (6,322 units at $46.29), increasing direct ownership by 0.16% to 1,111,983 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 73,176 shares at a strike of $25.30 and sold $2,557,144 worth of shares (55,578 units at $46.01), increasing direct ownership by 2% to 1,110,231 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- President, CEO Khattar Jack A. exercised 55,974 shares at a strike of $12.98 and sold $1,569,430 worth of shares (34,800 units at $45.10), increasing direct ownership by 2% to 1,092,633 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Newhall Charles W Iii sold $161,496 worth of shares (3,588 units at $45.01), decreasing direct ownership by 3% to 129,644 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Sr. VP of IP, CSO Bhatt Padmanabh P. converted options into 1,250 shares and covered exercise/tax liability with 581 shares, increasing direct ownership by 5% to 13,718 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- SVP, Quality, GMP, Ops, IT Mottola Frank exercised 14,000 shares at a strike of $12.98 and sold $623,140 worth of shares (14,000 units at $44.51) (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)
- Director Newhall Charles W Iii sold $45,000 worth of shares (1,000 units at $45.00), decreasing direct ownership by 0.74% to 133,232 units (SEC Form 4)4 - SUPERNUS PHARMACEUTICALS, INC. (0001356576) (Issuer)